1.160CAD+4.50%Mkt Cap: 12.11M CADP/E: —Last update: 2026-06-01
Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets AGGRASTAT injection, a glycoprotein GP IIb/IIIa recepto…
Industry Peers
Drug Manufacturers - Specialty & Generic150.78BSEKP/E 166.4
58.93BTRY—
56.89BEURP/E 22.4
32.78BPLNP/E 21.4
23.20BUSDP/E 20.2
18.39BUSD—
16.21BUSDP/E 24.8
13.00BTRY—
Indicators:|
Key Statistics
Company
Market Cap12.11M CAD
Enterprise Value10.85M CAD
Revenue (TTM)31.32M CAD
Gross Profit11.75M CAD
Net Income (TTM)-7.10M CAD
Revenue/Share3.001 CAD
Last Price1.160 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA58469E4085
Valuation
P/E (Trailing)—
P/E (Forward)-3.58
PEG0.17
EV/EBITDA-2.22
EV/Revenue0.35
P/S0.37
P/B0.90
EPS (TTM)-0.65
EPS (Forward)-0.31
52W Range
0.850053% of range1.430
52W High1.430 CAD
52W Low0.8500 CAD
Profitability
Gross Margin40.71%
Oper. Margin-4.62%
EBITDA Margin-15.59%
Profit Margin-24.60%
ROE-54.98%
ROA-28.45%
Growth
Revenue Growth44.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-560.00K CAD
CapEx (TTM)—
FCF Margin-3.15%
FCF Yield-8.16%
Net Debt-739.00K CAD
Net Debt/EBITDA0.15
Balance Sheet
Debt/Equity0.07
Current Ratio1.04
Quick Ratio0.70
Book Value/Sh1.237 CAD
Cash/Share0.1480 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:15
Split DateNov 2, 2012
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.10.44M
Float5.28M
Insiders26.60%
Institutions23.10%
Short Interest
Short Ratio1.2d
Short % Float0.03%
Short % Out.0.02%
Shares Short2.53K
Short (prev mo.)2.53K
Technical
SMA 501.155 (+0.4%)
SMA 2001.149 (+0.9%)
Beta0.97
S&P 52W Chg27.70%
Avg Vol (30d)2.39K
Avg Vol (10d)2.02K
Technical Indicators
RSI (14)46.3
MACD-0.0126
MACD Signal-0.0068
MACD Hist.-0.0058
BB Upper1.269 CAD
BB Middle1.134 CAD
BB Lower0.9992 CAD
BB Width23.77%
ATR (14)0.0480 CAD
Vol Ratio (20d)0.00x